To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
Shanghai Bovax Biotechnology Co., Ltd.
Shanghai Bovax Biotechnology Co., Ltd.
LEO Pharma
Verrica Pharmaceuticals Inc.
Novan, Inc.
Beijing Health Guard Biotechnology, Inc
ViroXis Corporation
Novartis
G&E Herbal Biotechnology Co., LTD
Vaxart
Maruho Co., Ltd.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC